← Eichor
Study identifier: NCT06546033 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis

Condition: Multiple Sclerosis · Intermittent Fasting  ·  Sponsor: Nigde Omer Halisdemir University

PhaseNA
Planned participants34
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Elif Gökçe İnbaşı, MSc.  ·  0388 311 86 00  ·  einbasi@ohu.edu.tr

Nihan Çakır Biçer, PhD.  ·  nihan.bicer@acibadem.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Nigde Omer Halisdemir UniversityNiğde, Bor, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06546033